Extracellular vesicles carrying cancer-associated signatures are central to Mercy BioAnalytics’ blood-based ovarian cancer screening approach, now advancing into a pivotal clinical validation study...
Read More »
Extracellular vesicles isolated from patient blood using size-exclusion chromatography show potential for cancer diagnosis, clinical assessment, and...
Read More »
Extracellular vesicles are being evaluated as stable blood-based biomarkers to support early ovarian cancer screening and improve detection before symptoms develop...
Read More »
Engineered extracellular vesicles selectively delivered therapeutic cargo to ovarian tumors, demonstrating a scalable strategy for targeted cancer treatment...
Read More »
INOVIQ reported extracellular vesicles engineered as CAR exosomes achieved strong tumor killing in ovarian cancer models, supporting development...
Read More »
A novel liquid biopsy platform uses extracellular vesicles captured by antibody-conjugated nanowires to enable sensitive cancer detection and microRNA profiling from blood samples...
Read More »
Extracellular vesicles engineered for targeted delivery enable selective accumulation in ovarian tumors, with exosomes supporting precise cargo...
Read More »
A novel blood test using extracellular vesicles achieved 89% sensitivity and 98% specificity for early-stage ovarian cancer, offering a promising...
Read More »
Mercy BioAnalytics secured $59 million in series B financing to advance extracellular vesicles-based liquid biopsy tests, including its Halo ovarian cancer screening portfolio, which shows exceptional sensitivity for early detection and promises expanded applications in multi-cancer and lung cancer screening...
Read More »
University of Queensland researchers developed mesoporous gold nanoparticles that enhance biosensors to detect ovarian cancer biomarkers in extracellular vesicles, offering a sensitive...
Read More »
Exosome RNA Exosome RNA Research & Industry News
